Cargando…
Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
INTRODUCTION: Current cancer research has led to a renewed interest in exploring lysosomal membrane permeabilization and lysosomal cell death as a targeted therapeutic approach for cancer treatment. Evidence suggests that differences in lysosomal biogenesis between cancer and normal cells might open...
Autores principales: | Shah, Harshit, Stankov, Metodi, Panayotova-Dimitrova, Diana, Yazdi, Amir, Budida, Ramachandramouli, Klusmann, Jan-Henning, Behrens, Georg M. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931186/ https://www.ncbi.nlm.nih.gov/pubmed/36816923 http://dx.doi.org/10.3389/fonc.2023.999738 |
Ejemplares similares
-
Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
por: Stankov, Metodi V., et al.
Publicado: (2013) -
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
por: Hernández-Tiedra, Sonia, et al.
Publicado: (2016) -
BAMBI Is Expressed in Endothelial Cells and Is Regulated by Lysosomal/Autolysosomal Degradation
por: Xavier, Sandhya, et al.
Publicado: (2010) -
Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells
por: Klose, Johannes, et al.
Publicado: (2014) -
WHAMM initiates autolysosome tubulation by promoting actin polymerization on autolysosomes
por: Dai, Anbang, et al.
Publicado: (2019)